Loading...
Loading...
Contributors:
Dataset URI:
10.5281/zenodo.23752560Release Version 2.7.0-VNN21-EpistemicAutoRepair-Audited: Closed-Loop 8-Channel Epistemic Verifier (LayaEpistemicVerifierV21), ID-Independent RDKit RWMol Chemical Graph Auto-Repair, Autonomous Discovery of C2-Deuterated AS-LRRK2-004-MOD_C2D (3,101x G2019S Selectivity), Local ChEMBL 37 Deep Selectivity Profiling (286,440 Empirical Assays), Harvard/MIT PyTDC v1.1.15 6-Oracle & 7-Clinical ADME/Tox Benchmark, Level 10 Regulatory & 3D Hydration Audit, Explicit 3D Cryo-EM Pocket Docking (RCSB PDB 8TXZ & 6VP6), Dual Live SIB SwissTargetPrediction Proteome Validation & 25-Claim Markush Patent ExpansionOriginated and developed by independent investigator Artyom Sokolov (infosokoloff@yandex.ru). Version 2.7.0 introduces the closed-loop epistemic verification and autonomous molecular graph surgery architecture alongside the complete 10-level computational and biophysical dossier:VNN v2.1 Closed-Loop Epistemic Verification & Autonomous RDKit Graph Surgery (vnn/universal_epistemic_verifier.py, vnn/epistemic_auto_repair.py, scripts/recalculate_parkinsons_lrrk2_multi_gate.py, data/parkinsons_lrrk2_recalculated_dossier.json):ID-Independent RDKit RWMol Graph Surgeries: Replaces identifier lookup tables with universal chemical graph transformations: (A) automated conversion of basic aryl-N-methylpiperazines (pKa = 8.4) into morpholines (pKa = 3.6), eliminating pulmonary phospholipidosis (CAD), dopamine D2 off-target risk, and cardiac hERG blockade; and (B) graph-level detection (_analyze_aox1_graph) of unshielded aromatic n-c-n pyrimidine carbons followed by isotopic C2-deuteration (C2-[2H], kH/kD ≥ 6.5) to block cytosolic aldehyde oxidase (AOX1) metabolism.Gate 4 Cardiac Safety Tightening (p(hERG) < 0.50): Enforces vnn_tox_prob < 0.50 in Gate 4 alongside CiPA qNet ≥ 0.06, strictly demoting un-deuterated AS-LRRK2-002 (p(hERG) = 0.540) from 84.0 to 64.0 / 100 while confirming 96.0 / 100 (PLATINUM_CLINICALLY_ROBUST_LEAD) for AS-LRRK2-005-MOD_DualD4, AS-LRRK2-005-MOD_C2D, AS-LRRK2-002-MOD_C2D (p(hERG) = 0.284), and AS-LRRK2-003-MOD_Morph.Autonomous Discovery of AS-LRRK2-004-MOD_C2D: Closed-loop verification of ultra-selective backup AS-LRRK2-004 (3,101x G2019S mutant selectivity, CNS MPO = 5.64, FaSSIF = 659.79 μg/mL) automatically detected its unshielded pyrimidine C2-H AOX1 liability and synthesized its C2-deuterated derivative [2H]c1nc(-c2n[nH]c3ccc(OC)cc23)c(F)c(N2CCOC[C@@H]2C)n1 (p(hERG) = 0.151, AOX1 liability reduced to 0.08).Harvard/MIT PyTDC v1.1.15 Comprehensive ADME/Tox & CNS Oracle Benchmark (PYTDC_HARVARD_MIT_BENCHMARK_REPORT.md, data/pytdc_harvard_mit_validation.json):Evaluated across 6 built-in PyTDC Oracles (QED, SA, LogP, DRD2, GSK3B, JNK3) and 7 clinical human ADME/Tox datasets (BBB_Martins, HIA_Hou, Bioavailability_Ma, Pgp_Broccatelli, hERG, AMES, DILI) with 7/7 passing Sample Power Gate, Canary Control, and 10x Monte Carlo Permutation Control.Lead candidates AS-LRRK2-005-MOD_DualD4 (QED = 0.777, BBB_Martins P = 0.688, HIA_Hou P = 0.894, Pgp P = 0.335) and achiral AS-LRRK2-006A (QED = 0.772, SA = 2.92, BBB_Martins P = 0.711) outperform clinical comparator BIIB122 (QED = 0.602, SA = 3.40, BBB_Martins P = 0.573, Pgp P = 0.431).ChEMBL 37 Deep Selectivity & Safety Profiling (CHEMBL37_DEEP_SELECTIVITY_AND_SAFETY_DOSSIER.md):Benchmarked across 286,440 empirical pharmacological measurements across 12 critical human targets from the local ChEMBL 37 SQLite database (28.39 GB).AS-LRRK2-005-MOD_DualD4 achieves a >167-fold TTK/MPS1 mitotic safety window (vs 12x for BIIB122), 17,500-fold hERG margin, 25,000-fold D2 receptor margin, and 30,000-fold AOX1 stability margin.Explicit 3D Cryo-EM Pocket Docking (8TXZ & 6VP6), Dual Live SIB SwissTargetPrediction & 254/254 Automated Test Suite: Includes 20 3D docked poses, 25 Markush patent claims, bilingual 4-Lot CRO synthesis RFQ, and 254/254 passing automated pytest tests (213 Repo + 30 VNN v2.1 + 11 Multi-Gate = 100.0% Zero-Regression).
Keyword(s):
6VP6; 8TXZ; AS-LRRK2-004-MOD_C2D; AS-LRRK2-005; AS-LRRK2-006.
MeSH Term(s):
Grants and Funding:
No Grants or Funding Data Available
Associated Publication(s):
No Associated Publication Data Available
Supplementary Data:
No Supplementary Data Available
Related Dataset(s):
No Related Dataset Data Available
The National Library of Medicine (NLM) provides information about biomedical datasets. Inclusion on an NLM Web page does not imply endorsement of, or agreement with, the contents by NLM or the National Institutes of Health. Learn more: NLM Web Policies (nih.gov)